SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (SRIA), receiving recognition from the industry organization for its work in developing and commercializing robotic surgery technology (https://ibn.fm/lDfv9). The company was selected over nine other finalists, including several established medical technology companies active in robotic surgery.
The award comes as adoption of the SSi Mantra surgical robotic system continues to expand, with more than 11,700 procedures completed globally. SSi Mantra has received regulatory approvals in 14 countries, supporting the company’s international growth strategy. More than 2,100 physicians have been trained on the company’s robotic surgery platform, which has been used across more than 170 different procedures.
For investors, the recognition provides an independent industry endorsement as SS Innovations continues to expand its presence in the rapidly growing global surgical robotics market. The surgical robotics industry has become increasingly competitive as healthcare providers adopt robotic-assisted procedures across multiple specialties and manufacturers seek to expand beyond traditional markets.
The award was presented to SS Innovations after the company was selected from a field of finalists that included some of the largest and most established players in the medical technology sector. This recognition underscores the company's progress in developing a versatile robotic platform that can be deployed across a wide range of surgical specialties, potentially offering cost-effective solutions for healthcare systems worldwide.
The SSi Mantra system has been particularly noted for its modular design, which allows hospitals to customize configurations based on their specific surgical needs. This flexibility, combined with the company's focus on training and support, has helped drive adoption in both developed and emerging markets. The company's regulatory approvals across 14 countries demonstrate its ability to navigate diverse healthcare regulatory environments.
As the global surgical robotics market continues to expand, driven by technological advancements and increasing demand for minimally invasive procedures, SS Innovations is positioning itself as a key player. The Outstanding Company award from SRIA serves as a validation of the company's strategy and execution, potentially enhancing its reputation among healthcare providers, partners, and investors.
Forward-looking statements in this article involve risks and uncertainties, as detailed in the company's SEC filings. All parties undertake no duty to update this information unless required by law.
